1
|
Somsak P, Piboonratanakit P, Pongsiriwet S, Sappayatosok K, Sarideechaigul W, Taebunpakul P, Pimolbutr K, Ayudhya CCN, Pengpis N, Wiriyakijja P. Development and validation of the Oral Lichen Planus-Disease Activity Scale: a novel tool for comprehensive clinical assessment. Clin Oral Investig 2024; 28:481. [PMID: 39129032 DOI: 10.1007/s00784-024-05875-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/02/2024] [Accepted: 08/05/2024] [Indexed: 08/13/2024]
Abstract
OBJECTIVE To develop and validate the Oral Lichen Planus-Disease Activity Scale (OLP-DAS) for assessing overall disease activity of OLP. METHODS The OLP-DAS was created by refining the Thongprasom criteria, incorporating inputs from the literature and expert review, and integrating pain assessment. Content validity was evaluated in a virtual meeting with 8 Oral Medicine specialists. Reliability and validity of the final version were examined. Seventeen OLP subjects were assessed for disease activity by 10 investigators using the OLP-DAS, Oral Disease Severity Score (ODSS), OLP-Investigator Global Assessment (OLP-IGA), and Reticular-Erythema-Ulcerative (REU) scale. Convergent validity was assessed by rating 160 OLP subjects using the OLP-DAS, ODSS, and OLP-IGA. Inter-rater and intra-rater reliability, along with convergent validity, were analyzed using intraclass correlation coefficients (ICCs) and Spearman's rank correlation coefficients (rs). RESULTS The final OLP-DAS achieved excellent content validity indices. Inter-rater and intra-rater ICCs for total OLP-DAS scores were 0.93 and 0.96, respectively. Total OLP-DAS scores exhibited strong positive correlations with the ODSS and OLP-IGA (rs = 0.94 and rs = 0.76; P < 0.001, respectively). The OLP Severity Index (OLP-SI), a component of the OLP-DAS, showed very strong positive correlations with OLP disease activity parameters of the ODSS (rs = 0.90; P < 0.001). CONCLUSIONS The OLP-DAS is a valid and reliable clinician-reported outcome measure (CROM) for evaluating OLP disease activity. CLINICAL RELEVANCE The OLP-DAS, as a standardized CROM for OLP, is valuable for both routine clinical assessments and research applications.
Collapse
Affiliation(s)
- Preeyaporn Somsak
- Department of Oral Medicine, Faculty of Dentistry, Chulalongkorn University, 34 Henri-Dunant Road, Wangmai, Pathumwan, Bangkok, 10330, Thailand
- Faculty of Dentistry, Thammasat University, Pathum Thani, Thailand
| | - Pornpan Piboonratanakit
- Department of Oral Medicine, Faculty of Dentistry, Chulalongkorn University, 34 Henri-Dunant Road, Wangmai, Pathumwan, Bangkok, 10330, Thailand
| | | | | | | | | | - Kununya Pimolbutr
- Department of Oral Medicine and Periodontology, Faculty of Dentistry, Mahidol University, Bangkok, Thailand
| | | | - Nawaporn Pengpis
- Faculty of Dentistry, Thammasat University, Pathum Thani, Thailand
| | - Paswach Wiriyakijja
- Department of Oral Medicine, Faculty of Dentistry, Chulalongkorn University, 34 Henri-Dunant Road, Wangmai, Pathumwan, Bangkok, 10330, Thailand.
- Avatar Biotechnologies for Oral Health and Healthy Longevity Research Unit, Faculty of Dentistry, Chulalongkorn University, Bangkok, Thailand.
| |
Collapse
|
2
|
Hashemipour MA, Sheikhhoseini S, Afshari Z, Gandjalikhan Nassab AR. The relationship between clinical symptoms of oral lichen planus and quality of life related to oral health. BMC Oral Health 2024; 24:556. [PMID: 38735922 PMCID: PMC11089796 DOI: 10.1186/s12903-024-04326-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/26/2024] [Accepted: 05/03/2024] [Indexed: 05/14/2024] Open
Abstract
INTRODUCTION Oral Lichen Planus (OLP) is a chronic and relatively common mucocutaneous disease that often affects the oral mucosa. Although, OLP is generally not life-threatening, its consequences can significantly impact the quality of life in physical, psychological, and social aspects. Therefore, the aim of this research is to investigate the relationship between clinical symptoms of OLP and oral health-related quality of life in patients using the OHIP-14 (Oral Health Impact Profile-14) questionnaire. MATERIALS AND METHODS This descriptive-analytical study has a cross-sectional design, with case-control comparison. In this study, 56 individuals were examined as cases, and 68 individuals were included as controls. After recording demographic characteristics and clinical features by reviewing patients' records, the OHIP-14 questionnaire including clinical severity of lesions assessed using the Thongprasom scoring system, and pain assessed by the Visual Analog Scale (VAS) were completed. The ADD (Additive) and SC (Simple Count) methods were used for scoring, and data analysis was performed using the T-test, Mann-Whitney U test, Chi-Square, Spearman's Correlation Coefficient, and SPSS 24. RESULTS Nearly all patients (50 individuals, 89.3%) reported having pain, although the average pain intensity was mostly mild. This disease has affected the quality of life in 82% of the patients (46 individuals). The patient group, in comparison to the control group, significantly expressed a lower quality of life in terms of functional limitations and physical disability. There was a statistically significant positive correlation between clinical symptoms of OLP, gender, location (palate), and clinical presentation type (erosive, reticular, and bullous) of OLP lesions with OHIP-14 scores, although the number or bilaterality of lesions and patient age did not have any significant correlation with pain or OHIP scores. CONCLUSION It appears that certain aspects of oral health-related quality of life decrease in patients with OLP, and that of the OLP patient group is significantly lower in terms of functional limitations and physical disability compared to the control group. Additionally, there was a significant correlation between clinical symptoms of OLP and pain as well as OHIP scores.
Collapse
Affiliation(s)
- Maryam Alsadat Hashemipour
- Kerman Social Determinants On Oral Health Research Center, Kerman University of Medical Sciences, Kerman, Iran.
- Department of Oral Medicine, School of Dentistry, Kerman University of Medical Sciences, Kerman, Iran.
| | - Sahab Sheikhhoseini
- Dentist. Member of Kerman Social Determinants On Oral Health Research Center, Kerman University of Medical Sciences, Kerman, Iran
| | | | | |
Collapse
|
3
|
Brennan MT, Riordain RN, Long-Simpson L, Bissonnette C, Lizano M, Madsen LS. Oral lichen planus clinician reported outcome measure: Development, content validity, and further development. Oral Dis 2023; 29:3400-3407. [PMID: 36349483 DOI: 10.1111/odi.14430] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/10/2022] [Revised: 10/05/2022] [Accepted: 10/26/2022] [Indexed: 11/10/2022]
Abstract
OBJECTIVE To establish and test a clinician-reported outcome measure of oral lichen planus (OLP): OLP Investigator global assessment (IGA). METHODS OLP IGA scale was tested with retrospective data from clinical practice and a phase II clinical trial. A comparison of the OLP IGA score with patient-reported outcomes was completed. RESULTS Clinical Practice: The mean (SD) OLP IGA score (0-4) in 107 OLP patients was 1.8 (1.0) with correlation of 0.25-0.48 (p value 0.01 - <0.0001) with symptom scores. There was a significant increase in OLP symptoms based on OLP IGA score. CLINICAL TRIAL The mean (SD) OLP IGA score in 137 research participants was 2.5 (1.2) with correlation of 0.43-0.52 (all p values <0.0001) with symptoms scores. There was a significant increase in OLP symptoms based on OLP IGA score. Forty-seven (35%) participants in the phase 2 study had an improvement in the OLP IGA score of ≥2. There were significant improvements in all symptoms scores in relation to the change in IGA score. CONCLUSIONS The OLP IGA is designed to assess changes in symptomatic OLP lesions and is appropriate for use across the full range of symptomatic OLP severity and represents a scale with utility in clinical practice and clinical trials.
Collapse
Affiliation(s)
- Michael T Brennan
- Department of Oral Medicine/Oral & Maxillofacial Surgery, Atrium Health Carolinas Medical Center, Charlotte, North Carolina, USA
- Department of Otolaryngology/Head and Neck Surgery, Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA
| | - Richeal Ni Riordain
- Oral Medicine Unit, Cork University Dental School and Hospital, Cork, Ireland
| | | | - Caroline Bissonnette
- Department of Oral Medicine/Oral & Maxillofacial Surgery, Atrium Health Carolinas Medical Center, Charlotte, North Carolina, USA
- Department of Stomatology, Faculty of Dentistry, University of Montreal, Montreal, Canada
| | - Marcela Lizano
- Department of Oral Medicine/Oral & Maxillofacial Surgery, Atrium Health Carolinas Medical Center, Charlotte, North Carolina, USA
| | | |
Collapse
|
4
|
Mahon-Smith A, Skingley G, Ayala-Nunes L, Batish A, Sharp R, Naujoks C, Schruf E, Compagno N, Moreno SG. Evaluating the Appropriateness of Existing Health-Related Quality of Life Measures in Lichen Planus. Dermatol Ther (Heidelb) 2023; 13:2817-2837. [PMID: 37794275 PMCID: PMC10613190 DOI: 10.1007/s13555-023-00990-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/17/2023] [Accepted: 07/19/2023] [Indexed: 10/06/2023] Open
Abstract
INTRODUCTION Lichen planus (LP) is an inflammatory skin disorder that can present in various forms across the body, including lesions on the skin (cutaneous LP [CLP]), scalp (lichen planopilaris [LPP]) and mucosal regions (mucosal LP [MLP]). Several existing patient-reported outcome measures (PROMs) were identified for potential use in LP clinical development programs. This study aimed to assess the content validity and psychometric measurement properties of the Dermatology Life Quality Index (DLQI), Epworth Sleepiness Scale (ESS), Scalpdex and Oral Lichen Planus Symptom Severity Measure (OLPSSM) in an LP population. METHODS Patients completed the PROs at various time points as part of an international Phase 2 clinical study in adults with MLP (n = 37), LPP (n = 37) and CLP (n = 37). Test-retest reliability, construct validity and sensitivity to change were assessed. In addition, qualitative cognitive debriefing interviews were conducted with adults with MLP (n = 20), LPP (n = 19) and CLP (n = 19) in the USA and Germany to examine the PROM content validity. RESULTS The DLQI demonstrated adequate reliability and validity, although its ability to detect change was modest and most items were considered not relevant in qualitative interviews. The ESS had good reliability but limited evidence of validity and ability to detect change. Conceptual relevance varied according to the qualitative interview data. The Scalpdex was miscellaneous across domains, but the 'Symptoms' domain performed well overall. Overall, Scalpdex concepts were reported as relevant by most LPP patients interviewed. The OLPSSM demonstrated good psychometric properties and strong evidence of content validity. CONCLUSIONS The psychometric and qualitative findings support the use of the OLPSSM and Scalpdex within specific LP subtypes but cautioned use of the DLQI. Administration of the ESS is not recommended in LP because of its poor psychometric performance. Given these limitations, further validation of non-specific disease measures is needed and/or the development of additional LP-specific PROMs. TRIAL REGISTRATION NCT04300296.
Collapse
Affiliation(s)
- Aoife Mahon-Smith
- Patient-Centered Outcomes, Adelphi Values Ltd, Bollington, Cheshire, UK.
| | - George Skingley
- Patient-Centered Outcomes, Adelphi Values Ltd, Bollington, Cheshire, UK
| | - Lara Ayala-Nunes
- Patient-Centered Outcomes, Adelphi Values Ltd, Bollington, Cheshire, UK
| | - Anjali Batish
- Patient-Centered Outcomes, Adelphi Values Ltd, Bollington, Cheshire, UK
| | - Rosie Sharp
- Patient-Centered Outcomes, Adelphi Values Ltd, Bollington, Cheshire, UK
| | | | | | | | | |
Collapse
|
5
|
Mahon-Smith A, Clifford M, Batish A, Sharp R, Panter C, Naujoks C, Schruf E, Compagno N, Moreno SG. Patient Experience of Lichen Planus: A Qualitative Exploration of Signs, Symptoms, and Health-Related Quality of Life Impacts. Dermatol Ther (Heidelb) 2023; 13:2001-2017. [PMID: 37505393 PMCID: PMC10442305 DOI: 10.1007/s13555-023-00968-2] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/03/2023] [Accepted: 06/14/2023] [Indexed: 07/29/2023] Open
Abstract
INTRODUCTION Lichen planus (LP) is an inflammatory skin disorder that can present in various forms across the body, including lesions on the skin (cutaneous LP [CLP]), scalp (lichen planopilaris [LPP]), and mucosal regions (mucosal LP [MLP]). Qualitative exploration of the patient experience of LP, notably symptoms and impacts on health-related quality of life (HRQoL), is limited. A scarcity of research was also identified relating to emotional wellbeing impacts of CLP patients. Two qualitative studies were conducted with LP patients to address these gaps. METHODS Study 1 consisted of exit interviews conducted with a subset of adult patients with MLP (n = 5), CLP (n = 4), and LPP (n = 4) enrolled in an LP clinical study in the United States (US) to explore the patient experience. Study 2 consisted of independent qualitative interviews conducted with adult CLP patients (n = 13) from the US and Germany to further explore impacts on emotional wellbeing. RESULTS Exit interviews found that itch , pain, and skin lesions were most frequently reported as signs/symptoms of LP. Itch and skin lesions were experienced across all LP subtypes, while pain was only reported by CLP and MLP patients. These signs/symptoms impacted HRQoL including emotional wellbeing (frustration, embarrassment), daily activities (oral hygiene, clothing options), social functioning (intimacy, social activities), and physical functioning (chewing/swallowing, opening/moving mouth). Impacts on activities of daily living (ADL) and physical functioning were mostly experienced by MLP patients. Independent qualitative interviews, which further explored impacts of CLP on patients' emotional wellbeing, identified frustration, worry, sadness, embarrassment, and depression as the most frequently experienced. CONCLUSION The findings contribute to the literature by providing qualitative insights into signs/symptoms and HRQoL impacts of LP, from the adult patient perspective. The findings also highlight the importance of considering assessment of HRQoL impacts in future clinical LP research, particularly impacts on emotional wellbeing when selecting instruments for assessment of HRQoL in the CLP population. TRIAL REGISTRATION NCT04300296.
Collapse
Affiliation(s)
- Aoife Mahon-Smith
- Patient-Centered Outcomes, Adelphi Values Ltd, Bollington, Cheshire, UK.
| | - Molly Clifford
- Patient-Centered Outcomes, Adelphi Values Ltd, Bollington, Cheshire, UK
| | - Anjali Batish
- Patient-Centered Outcomes, Adelphi Values Ltd, Bollington, Cheshire, UK
| | - Rosie Sharp
- Patient-Centered Outcomes, Adelphi Values Ltd, Bollington, Cheshire, UK
| | - Charlotte Panter
- Patient-Centered Outcomes, Adelphi Values Ltd, Bollington, Cheshire, UK
| | | | | | | | | |
Collapse
|
6
|
Brennan MT, Madsen LS, Saunders DP, Napenas JJ, McCreary C, Ni Riordain R, Pedersen AML, Fedele S, Cook RJ, Abdelsayed R, Llopiz MT, Sankar V, Ryan K, Culton DA, Akhlef Y, Castillo F, Fernandez I, Jurge S, Kerr AR, McDuffie C, McGaw T, Mighell A, Sollecito TP, Schlieve T, Carrozzo M, Papas A, Bengtsson T, Al-Hashimi I, Burke L, Burkhart NW, Culshaw S, Desai B, Hansen J, Jensen P, Menné T, Patel PB, Thornhill M, Treister N, Ruzicka T. Efficacy and Safety of a Novel Mucoadhesive Clobetasol Patch for Treatment of Erosive Oral Lichen Planus. J Oral Pathol Med 2021; 51:86-97. [PMID: 34907617 DOI: 10.1111/jop.13270] [Citation(s) in RCA: 12] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/10/2021] [Revised: 11/29/2021] [Accepted: 12/07/2021] [Indexed: 11/27/2022]
Abstract
BACKGROUND Oral lichen planus (OLP) is a chronic inflammatory disorder of the oral mucosa. Currently there is no approved treatment for oral lichen planus (OLP). We report on the efficacy and safety of a novel mucoadhesive clobetasol patch (Rivelin® -CLO) for the treatment of OLP. METHODS Patients with confirmed OLP and measurable symptomatic ulcer(s) participated in a randomized, double-blind, placebo-controlled, multicenter clinical trial testing a novel mucoadhesive clobetasol patch (Rivelin® -CLO) in OLP across Europe, Canada and USA. Patients were randomized to placebo (non-medicated), 1, 5, 20 µg Clobetasol/patch, twice daily, for 4 weeks. The primary endpoint was change in total ulcer area compared to baseline. Secondary endpoints included improvement from baseline in pain, disease activity, and quality of life. RESULTS Data were analyzed and expressed as mean [SD]. One hundred thirty-eight (138) patients were included in the study; 99 females and 39 males, mean age was 61.1 [11.6] years. Statistical analyses revealed that treatment with 20-μg Rivelin® -CLO patches demonstrated significant improvement with ulcer area (P=0.047), symptom severity (P=0.001), disease activity (P=0.022), pain (P=0.012), and quality of life (P=0.003) as compared with placebo. Improvement in OLP symptoms from beginning to the end of the study was reported as very much better (best rating) in the 20-µg group (25/32) patients compared to the placebo group (11/30), (P=0.012). Adverse events were mild/moderate. Candidiasis incidence was low (2%). CONCLUSIONS Rivelin® -CLO patches were superior to placebo demonstrating statistically significant, clinically relevant efficacy in objective and subjective improvement and, with a favorable safety profile.
Collapse
Affiliation(s)
- Michael T Brennan
- Atrium Health Carolinas Medical Center, Department of Oral Medicine, Charlotte, NC, USA
| | | | - Deborah P Saunders
- Health Sciences North, Northeast Cancer Centre, Sudbury, Ontario, Canada; Northern Ontario School of Medicine, Sudbury, Ontario, Canada
| | - Joel J Napenas
- Atrium Health Carolinas Medical Center, Department of Oral Medicine, Charlotte, NC, USA
| | - Christine McCreary
- Cork University Dental School and Hospital, College of Medicine and Health, University College Cork, Ireland
| | - Richeal Ni Riordain
- Cork University Dental School and Hospital, College of Medicine and Health, University College Cork, Ireland
| | | | - Stefano Fedele
- University College London, UCL Eastman Dental Institute and UCLH NIHR Biomedical Research Centre, London, UK
| | - Richard J Cook
- King´s College London, Faculty of Dentistry Oral & Craniofacial Sciences, Oral Medicine & Oral Clinical Research Unit, Guy's Hospital Campus, London, UK
| | - Rafik Abdelsayed
- The Dental College of Georgia, Augusta University, Augusta, GA, USA
| | | | - Vidya Sankar
- Division of Oral Medicine and Dentistry, Brigham and Women's Hospital, Boston, MA, USA.,Tufts University School of Dental Medicine, Boston, MA, USA
| | - Kevin Ryan
- University of Glasgow Hospital & Dental School, Glasgow, UK
| | - Donna A Culton
- University of North Carolina at Chapel Hill, Department of Dermatology, Chapel Hill, NC, USA
| | - Yousra Akhlef
- Department of Oral & Maxillofacial Surgery, Copenhagen University Hospital (Rigshospitalet), Copenhagen, Denmark
| | | | | | - Sabine Jurge
- University of Sheffield School of Clinical Dentistry, Sheffield, UK
| | | | | | - Tim McGaw
- Kaye Edmonton Clinic, Edmonton, Alberta, Canada
| | - Alan Mighell
- School of Dentistry, The University of Leeds, Leeds, UK
| | - Thomas P Sollecito
- School of Dental Medicine, University of Pennsylvania, Philadelphia, PA, USA
| | | | - Marco Carrozzo
- School of Dental Sciences, Newcastle University, Newcastle, UK
| | - Athena Papas
- Tufts University School of Dental Medicine, Boston, MA, USA
| | | | - Ibtisam Al-Hashimi
- UT Southwestern Medical Center, Dallas, TX, USA.,Currently Scientific Consultant
| | | | - Nancy W Burkhart
- The International Oral Lichen Planus Support Group, Texas A&M University College of Dentistry, Dallas, TX, USA
| | - Shauna Culshaw
- University of Glasgow Hospital & Dental School, Glasgow, UK
| | - Bhavik Desai
- TMJ & Orofacial Treatment Centers of Wisconsin, WI, USA
| | | | - Pia Jensen
- Afyx Therapeutics A/S, Copenhagen, Denmark
| | | | - Paras B Patel
- Texas A&M University College of Dentistry, Dallas, TX, USA
| | - Martin Thornhill
- Atrium Health Carolinas Medical Center, Department of Oral Medicine, Charlotte, NC, USA.,University of Sheffield School of Clinical Dentistry, Sheffield, UK
| | - Nathaniel Treister
- Division of Oral Medicine and Dentistry, Brigham and Women's Hospital, Boston, MA, USA
| | | |
Collapse
|
7
|
Wiriyakijja P, Porter S, Fedele S, Hodgson T, McMillan R, Shephard M, Riordain RN. Health-related quality of life and its associated predictors in patients with oral lichen planus: a cross-sectional study. Int Dent J 2020; 71:140-152. [PMID: 32875594 PMCID: PMC9275316 DOI: 10.1111/idj.12607] [Citation(s) in RCA: 14] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/14/2022] Open
Abstract
OBJECTIVES To investigate levels of quality of life (QoL) and determine associated predictors in patients with oral lichen planus (OLP). MATERIALS AND METHODS A total of 300 patients with OLP at one tertiary Oral Medicine clinic in the UK were recruited in a cross-sectional study from January 2018 to July 2019. The 15-item Chronic Oral Mucosal Disease Questionnaire (COMDQ-15) and 14-item Oral Health Impact Profile (OHIP-14) were used to assess the level of QoL related to OLP. A number of potential determinants were considered, including patient demographics, treatment, the severity of oral symptoms, the clinical activity of the disease, and the patient psychological status, which were measured using the pain-Numerical Rating Scale, the Oral Disease Severity Score, the Hospital Anxiety and Depression Scale, and the 10-item Perceived Stress Scale. Multivariate linear regression was employed to identify independent determinants associated with overall and aspects of QoL. RESULTS On multivariate analyses, after adjusting for confounding variables, the QoL levels in patients with OLP were significantly associated with levels of oral pain, anxiety, stress and use of topical corticosteroids. The COMDQ-15 instrument performed better than OHIP-14 at capturing the association between QoL and pain and disease activity in patients with OLP. CONCLUSION Clinicians should expect reduced QoL in OLP patients with high pain levels, high anxiety levels, high perceived stress and use of topical corticosteroids. The COMDQ-15 is best suited to measure QoL in this population.
Collapse
Affiliation(s)
- Paswach Wiriyakijja
- UCL Eastman Dental Institute, London, UK
- Department of Oral Medicine, Faculty of Dentistry, Chulalongkorn University, Bangkok, Thailand
| | | | - Stefano Fedele
- UCL Eastman Dental Institute, London, UK
- NIHR University College London Hospitals Biomedical Research Centre, London, UK
| | - Tim Hodgson
- Royal National ENT & Eastman Dental Hospitals, UCLH Foundation NHS Trust London, London, UK
| | - Roddy McMillan
- Royal National ENT & Eastman Dental Hospitals, UCLH Foundation NHS Trust London, London, UK
| | - Martina Shephard
- Royal National ENT & Eastman Dental Hospitals, UCLH Foundation NHS Trust London, London, UK
| | - Richeal Ni Riordain
- UCL Eastman Dental Institute, London, UK
- Department of Oral Medicine, Cork University Dental School and Hospital, Cork, Ireland
| |
Collapse
|
8
|
Osipoff A, Carpenter MD, Noll JL, Valdez JA, Gormsen M, Brennan MT. Predictors of symptomatic oral lichen planus. Oral Surg Oral Med Oral Pathol Oral Radiol 2020; 129:468-477. [DOI: 10.1016/j.oooo.2019.12.019] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/29/2019] [Revised: 12/30/2019] [Accepted: 12/30/2019] [Indexed: 01/07/2023]
|
9
|
Wiriyakijja P, Porter S, Fedele S, Hodgson T, McMillan R, Shephard M, Ni Riordain R. Validation of the HADS and PSS‐10 and psychological status in patients with oral lichen planus. Oral Dis 2019; 26:96-110. [DOI: 10.1111/odi.13220] [Citation(s) in RCA: 19] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/11/2019] [Revised: 09/16/2019] [Accepted: 10/22/2019] [Indexed: 12/12/2022]
Affiliation(s)
- Paswach Wiriyakijja
- UCL Eastman Dental Institute London UK
- Department of Oral Medicine Faculty of Dentistry Chulalongkorn University Bangkok Thailand
| | | | - Stefano Fedele
- UCL Eastman Dental Institute London UK
- NIHR University College London Hospitals Biomedical Research Centre London UK
| | - Tim Hodgson
- Eastman Dental Hospital UCLH Foundation NHS Trust London London UK
| | - Roddy McMillan
- Eastman Dental Hospital UCLH Foundation NHS Trust London London UK
| | - Martina Shephard
- Eastman Dental Hospital UCLH Foundation NHS Trust London London UK
| | - Richeal Ni Riordain
- UCL Eastman Dental Institute London UK
- Department of Oral Medicine Cork University Dental School and Hospital Cork Ireland
| |
Collapse
|